Where does LEO Laboratories Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), LEO Laboratories Limited ranks #12,516 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does LEO Laboratories Limited hold?

LEO Laboratories Limited holds 24 US utility patents granted between 2015 and 2018, spanning 11 technology areas.

What is LEO Laboratories Limited's Innovation Score?

LEO Laboratories Limited has an Innovation Score of 37.2 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does LEO Laboratories Limited focus on?

LEO Laboratories Limited's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 18 patents, ranking #1,261 of 7,163 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is LEO Laboratories Limited's patent grant rate increasing or decreasing?

LEO Laboratories Limited's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for LEO Laboratories Limited's patents?

LEO Laboratories Limited's patents average 24.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the LEO Laboratories Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

LEO Laboratories Limited

USPTO PatentsView assignee record - 24 granted patents across 11 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, LEO ranks #12,516 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 11 technology areas.

#12,516
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.2/100): 24.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12516 · Foreign Corporation #12,516 · 24 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 24 grants
MID-PACK #12,516/49,997
PHOTO-FINISH Kali Care
CPC-FOCUS A61K · 11 areas
INNOV-THIN 37.2/100
CLAIMS-DENSE 24.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Kali Care, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How LEO’s 37.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (30%) Velocity 0.0 pts (0%) Breadth 11.7 pts (31%) Claim depth 14.4 pts (39%)

Qualcomm Incorporated · highest

85
LEO Laboratories · this assignee

37
3D Lighting… · lowest

7

What this shows LEO's Innovation Score is 37.2/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for LEO?

Each dot is one of LEO’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). LEO’s own 24.0 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

LEO vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where LEO's grants concentrate

LEO Laboratories Limited is a focused PatentsView assignee: 11 CPC subclasses with 75% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (10 grants) versus a trough of 2 in 2015. By volume, LEO sits between Kali Care, Inc. and Lisnr, Inc..

Kali Care

24
Kurashiki Boseki

24
Laticrete Interna…

24
Legrand SNC

24
LG Magna E-powert…

24
Lghorizon

24
Linco Food System…

24
Lisnr

24
LEO Laboratories ◀

24

What this shows LEO holds 24 patents at rank #12,515, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near LEO

By rank, the assignees closest to #12,515 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in LEO's primary technology class.

LEO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

LEO Laboratories Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	8.3%
2016	9	37.5%
2017	10	41.7%
2018	3	12.5%

Which technologies does LEO Laboratories Limited patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 18

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 17

C07C - Acyclic OR Carbocyclic Compounds 10

C07D - Heterocyclic Compounds 5

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C12Y - Enzymes 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

LEO Laboratories Limited's patent record in context - here's where to go next.

LEO Laboratories Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 75% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #12,516 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare LEO Laboratories Limited against Kali Care, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.